Incidence of Hematologic and Non-Hematologic Malignancies, Thrombotic Events, and Autoimmune Disorders in Unrelated Normal Donors Undergoing Bone Marrow Harvest Versus Peripheral Blood Stem Cell Mobilization With Recombinant Human Granulocyte Colony-Stimulating Factor (rHuG-CSF)

Inclusion Criteria:

1. Unrelated donor who donated either unstimulated BM or filgrastim-mobilized PBSC
between July 1, 1999 and approximately five years post study activation.

2. Donation was managed by a U.S. NMDP donor center.

3. Signed informed consent for participation in this long-term donor follow-up study.

4. Concurrent enrollment on other studies is permitted (e.g. A Phase III Randomized
Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow
Transplantation from HLA Compatible Unrelated Donors (BMT CTN PvM Protocol 0201) and
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
(RDSafe).

Exclusion Criteria:

1. Unrelated donor who donated filgrastim-mobilized bone marrow.

2. Donation was managed by a non-U.S. donor center.

3. Donor is unable to verbally communicate in any of the following languages: English,
Spanish, Mandarin Chinese, Cantonese Chinese, Vietnamese, Korean, or Portuguese.